Protagonist Therapeutics logo

Protagonist Therapeutics Share Price Today

(NASDAQ: PTGX)

Protagonist Therapeutics share price is $38.45 & ₹3,343.96 as on 6 Mar 2025, 2.30 'hrs' IST

$38.45

-0.21

(-0.54%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Protagonist Therapeutics share price in Dollar and Rupees. Guide to invest in Protagonist Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Protagonist Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Protagonist Therapeutics share price movements

  • Today's Low: $37.68
    Today's High: $39.61

    Day's Volatility :4.87%

  • 52 Weeks Low: $24.22
    52 Weeks High: $48.89

    52 Weeks Volatility :50.46%

Protagonist Therapeutics (PTGX) Returns

PeriodProtagonist Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-7.25%
2.1%
0.0%
6 Months
-8.0%
-4.1%
0.0%
1 Year
23.63%
2.2%
0.0%
3 Years
62.1%
11.8%
-11.6%

Protagonist Therapeutics (PTGX) Key Statistics

in dollars & INR

Previous Close
$38.66
Open
$38.78
Today's High
$39.61
Today's Low
$37.68
Market Capitalization
$2.4B
Today's Volume
$466.2K
52 Week High
$48.89
52 Week Low
$24.22
Revenue TTM
$434.4M
EBITDA
$253.7M
Earnings Per Share (EPS)
$4.23
PE Ratio
9.1
Profit Margin
63.34%
Quarterly Earnings Growth YOY
3.51%
Return On Equity TTM
54.39%

How to invest in Protagonist Therapeutics Stock (PTGX) from India?

It is very easy for Indian residents to invest directly in Protagonist Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Protagonist Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Protagonist Therapeutics or PTGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Protagonist Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Protagonist Therapeutics shares which would translate to 0.023 fractional shares of Protagonist Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Protagonist Therapeutics, in just a few clicks!

Returns in Protagonist Therapeutics (PTGX) for Indian investors in Rupees

The Protagonist Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Protagonist Therapeutics investment value today

Current value as on today

₹1,27,924

Returns

₹27,924

(+27.92%)

Returns from Protagonist Therapeutics Stock

₹22,961 (+22.96%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Protagonist Therapeutics (PTGX)

100%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Protagonist Therapeutics Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Protagonist Therapeutics

  • BlackRock Inc

    16.10%

  • Farallon Capital Management, L.L.C.

    9.66%

  • RTW INVESTMENTS, LLC

    8.96%

  • Vanguard Group Inc

    6.87%

  • State Street Corp

    5.43%

  • Johnson & Johnson

    3.99%

Analyst Recommendation on Protagonist Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Protagonist Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Protagonist Therapeutics Stock (PTGX)

What analysts predicted

Upside of 55.01%

Target:

$59.60

Current:

$38.45

Insights on Protagonist Therapeutics Stock (Ticker Symbol: PTGX)

  • Price Movement

    In the last 7 days, PTGX stock has moved up by 6.9%
  • PTGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 37.4%
  • Price to Sales

    ForPTGX every $1 of sales, investors are willing to pay $5.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Protagonist Therapeutics Technicals Summary

Sell

Neutral

Buy

Protagonist Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Protagonist Therapeutics (PTGX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Protagonist Therapeutics Inc logo
3.92%
-8.0%
23.63%
62.1%
414.1%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Protagonist Therapeutics Inc logo
9.1
9.1
0.0
-1.24
0.54
0.29
NA
11.06
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Protagonist Therapeutics Inc logo
Buy
$2.4B
414.1%
9.1
63.34%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Protagonist Therapeutics

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Organization
Protagonist Therapeutics
Employees
126
CEO
Dr. Dinesh V. Patel Ph.D.
Industry
Health Technology

Management People of Protagonist Therapeutics

NameTitle
Dr. Dinesh V. Patel Ph.D.
CEO, President, Secretary & Director
Mr. Asif Ali
Executive VP & Chief Financial Officer
Dr. Suneel K. Gupta Ph.D.
Executive VP of Clinical Development
Mr. Mohammad Masjedizadeh Ph.D.
Executive VP & Chief Technical Officer
Dr. Newman Yeilding
EVP, Chief Scientific Officer
Mr. Matthew M. Gosling J.D.
Executive VP & General Counsel
Ms. Carena Spivey
Head of HR & Senior VP of Human Resources
Dr. Ashok Bhandari Ph.D.
Executive VP & Chief Drug Discovery and Preclinical Development Officer
Mr. Carter J. King
Executive Vice President of Business Development
Ms. Abha Bommireddi
Executive Vice President of Portfolio & Program Management

Important FAQs about investing in PTGX Stock from India :

What is Protagonist Therapeutics share price today?

Protagonist Therapeutics share price today stands at $38.45, Open: $38.78 ; Previous Close: $38.66 ; High: $39.61 ; Low: $37.68 ; 52 Week High: $48.89 ; 52 Week Low: $24.22.

The stock opens at $38.78, after a previous close of $38.66. The stock reached a daily high of $39.61 and a low of $37.68, with a 52-week high of $48.89 and a 52-week low of $24.22.

Can Indians buy Protagonist Therapeutics shares?

Yes, Indians can invest in the Protagonist Therapeutics (PTGX) from India.

With INDmoney, you can buy Protagonist Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Protagonist Therapeutics at zero transaction cost.

How can I buy Protagonist Therapeutics shares from India?

It is very easy to buy Protagonist Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Protagonist Therapeutics (PTGX) be purchased?

Yes, you can buy fractional shares of Protagonist Therapeutics with INDmoney app.

What are the documents required to start investing in Protagonist Therapeutics stocks?

To start investing in Protagonist Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Protagonist Therapeutics Stock (PTGX)?

Today’s highest price of Protagonist Therapeutics (PTGX) is $39.61.

Today’s lowest price of Protagonist Therapeutics (PTGX) is $37.68.

What is today's market capitalisation of Protagonist Therapeutics?

Today's market capitalisation of Protagonist Therapeutics PTGX is 2.4B

What is the 52 Week High and Low Range of Protagonist Therapeutics Stock (PTGX)?

  • 52 Week High

    $48.89

  • 52 Week Low

    $24.22

What are the historical returns of Protagonist Therapeutics (PTGX)?

  • 1 Month Returns

    3.92%

  • 3 Months Returns

    -8%

  • 1 Year Returns

    23.63%

  • 5 Years Returns

    414.1%

Who is the Chief Executive Officer (CEO) of Protagonist Therapeutics ?

Dr. Dinesh V. Patel Ph.D. is the current Chief Executive Officer (CEO) of Protagonist Therapeutics.